Fig. 6From: A multi-scale digital twin for adiposity-driven insulin resistance in humans: diet and drug effectsA Personalizing a digital twin using data from one person to train and validate a passive digital twin, such as the one presented herein, and making the digital twin active. This personalization can be in the form of input parameters, such as age and height, parameters estimated and validated on time-series data, such as meal response glucose, and input parameters representing activities, such as energy intake or topiramate dosage. B Using the digital twin to predict and compare scenarios with different lifestyles and/or treatments. In this example, the digital twin is used to predict two scenarios. In scenario 1, the digital twin simulates an increase in energy intake for 40Â years (from 40 to 80Â years of age) and a resulting increase in BMIâfrom overweight to obese levels (BMI over 25 and 30Â kg/m2, respectively)âand an increase in fasting plasma glucoseâfrom prediabetic to diabetic levels (fasting glucose above 5.6 and 7Â mmol/l, respectively). In Scenario 2, the digital twin simulates a decrease in energy intake with a weight-loss drug such as topiramate, resulting in a decrease to healthy levels of BMI and fasting plasma glucose. C Following the chosen lifestyle and getting continuous feedback by zooming in on 4Â weeks of the predicted fasting plasma glucose (solid line) and comparing with data (blue squares) collected by the user. Zooming in even more and looking at meal response glucose before and after the 4Â weeks, one can see that the glucose curve is higher before (left box) compared to after (right box), indicating an improvement in meal response glucose levels as wellBack to article page